Jennifer S. Bartholomew

The association of an HPV16 oncogene variant with HLA-B7 has implications for vaccine design in cervical cancer

John Ellis, Patrick Keating, J. W. Baird et al. · Nature Medicine · 1995 · 196 citations

Medicine, Immunology, Oncology +12

Global access to antifungal therapy and its variable cost

Matthew Kneale, Jennifer S. Bartholomew, Emma Davies et al. · Journal of Antimicrobial Chemotherapy · 2016 · 172 citations · Full text

Pharmacy, Pharmacoeconomics, Pharmacotherapy +17

Multiple mechanisms underlie HLA dysregulation in cervical cancer

Claire S. Brady, Jennifer S. Bartholomew, Deborah J. Burt et al. · Tissue Antigens · 2000 · 131 citations

Medicine, Immunology, Oncology +13

Integration of high-risk human papillomavirus DNA is linked to the down-regulation of class I human leukocyte antigens by steroid hormones in cervical tumor cells.

Jennifer S. Bartholomew, Suzanne Glenville, Shubhashish Sarkar et al. · PubMed · 1997 · 42 citations

Medicine, Immunology, Oncology +17

Identification of a naturally processed HLA A0201‐restricted viral peptide from cells expressing human papillomavirus type 16 E6 oncoprotein

Jennifer S. Bartholomew, Simon Stacey, Brian Coles et al. · European Journal of Immunology · 1994 · 36 citations

Life Sciences, Immunology, Oncology +17